Breakthrough CAR-T Therapy Used by First NHS Patient

Oscar Murphy, a 28-year-old man with a severe form of leukemia, has become the first patient to receive a groundbreaking treatment on the NHS that he described as “fantastic” and almost “sci-fi.” He was treated with CAR-T therapy at Manchester Royal Infirmary, which involves using his own modified immune cells to combat cancer.

Oscar received the initial infusion of this “living drug” on January 2. NHS England has decided to provide funding for this innovative immunotherapy across various centers, with hopes that around 50 patients will benefit from it annually.

Diagnosed in March 2025 with B-cell acute lymphoblastic leukemia (B-cell ALL), Oscar initially underwent chemotherapy and a donor stem cell transplant but was devastated to learn in November that his cancer had returned. “The leukemia I’ve got is so fast-acting,” explained Oscar, a car salesman from Bury. “It needs an even quicker response to stop it, and we’ve now got an answer for that.”

In clinical trials, 77% of patients observed went into remission post-treatment, with about half remaining cancer-free after three and a half years. On average, patients gained an additional 15.6 months of life. Oscar’s hematologist, Dr. Eleni Tholouli, noted that CAR-T therapy is generally safer than existing treatments, boasting fewer side effects and greater effectiveness. She highlighted how typically, patients with this kind of leukemia have lifespans that do not exceed six to eight months. “With this therapy, we can offer years, possibly even a cure,” she emphasized.

This therapy, which has recently been expanded to adults with B-cell ALL, uses T-cells, a type of white blood cell. Oscar’s samples were taken to a lab in Stevenage, where they were reengineered with a harmless virus to enhance their cancer-fighting abilities. The modified cells, now called CAR T-cells, multiply significantly in the lab, producing millions of copies ready for infusion.

Oscar expressed amazement at how such a small volume—just three teaspoons containing 100 million CAR T-cells—could deliver such a powerful impact. He stated, “It’s very sci-fi, but if it means it gets rid of the cancer permanently, it’s just fantastic.” His second infusion of 300 million cells was administered recently, completing his CAR-T therapy. These cancer-fighting T-cells will remain in his body, continuing to grow and operate after the treatment.

Manufactured by Autolus, a spin-off from University College London, the therapy was previously only available in US labs during clinical trials. Though the list price is £372,000 per infusion, the NHS provides a confidential discount. The therapy will be available for patients over 26 whose B-cell ALL hasn’t responded to treatment or has relapsed, with several English centers offering it. However, patients from Wales and Northern Ireland will need to travel to England for treatment, and approval in Scotland is still pending.

NHS England anticipates that about 50 patients each year could benefit, but Dr. Tholouli suggested that the potential number could be higher and added that it might eventually serve as a primary treatment instead of relying on stem cell transplants. Prof. Peter Johnson, the NHS National Clinical Director for Cancer, remarked that this moment is significant for patients dealing with aggressive blood cancers, and he praised the fact that this treatment arose from research originating in the UK.

Meanwhile, 29-year-old Chris Williams from Belfast, diagnosed with the same aggressive leukaemia in 2021 and treated with CAR-T therapy during its experimental phase, has been in remission for nearly three years. “A few years ago I was very unwell, and now I’m able to live a full life,” he shared, expressing gratitude for the support of his family and his engagement with Chloe.

In a notable twist, Oscar married his fiancé, Lauren, in the hospital last month amid uncertainties surrounding his treatment. They look forward to another ceremony in October. Oscar conveyed, “I want children and the white picket fence with my amazing wife. This is my gateway to doing it, and I can’t wait.”